Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Saline Solution × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

pembrolizumab 26 avelumab 20 Nivolumab 18 Ipilimumab 9 Radiotherapy 8 Cyclophosphamide 8 atezolizumab 7 fludarabine 6 cemiplimab 5 aldesleukin 5 Specimen Handling 5 Radiation 5 Interleukin-2 5 Biopsy 5 talimogene laherparepvec 4 durvalumab 4 Magnetic Resonance Spectroscopy 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Bevacizumab 3 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 budigalimab 2 Sirolimus 2 Paclitaxel 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03271372 2025-09-17

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡